Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers

A Functionally Significant Cross-talk between Androgen Receptor and ErbB2 Pathways in Estrogen Receptor Negative Breast Cancer

(2015) Ali Naderi et al.   NEOPLASIA

The androgen receptor in breast cancer: learning from the past

(2010) Michaela J. Higgins et al.   BREAST CANCER RESEARCH AND TREATMENT

Combinatorial biomarker expression in breast cancer

(2010) Emad A. Rakha et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

(2010) Isabella Castellano et al.   BREAST CANCER RESEARCH AND TREATMENT

Triple-Negative Breast Cancer

(2010) Ayca Gucalp et al.   CANCER JOURNAL

Breast Cancer Molecular Class ERBB2: Preponderance of Tumors With Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6, and EGFR

(2010) Rohit Bhargava et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Expression of androgen receptors in primary breast cancer

(2009) S. Park et al.   ANNALS OF ONCOLOGY

Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family

(2009) Sandeep Sanga et al.   BMC Medical Genomics

Androgen Receptor Inhibits Estrogen Receptor-  Activity and Is Prognostic in Breast Cancer

(2009) A. A. Peters et al.   CANCER RESEARCH

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

(2009) Leo A Niemeier et al.   MODERN PATHOLOGY

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

(2008) Zeina Nahleh   Future Oncology

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

(2008) Yoshinari Ogawa et al.   International Journal of Clinical Oncology

Hormonal approaches in prostate cancer: Application in the contemporary prostate cancer patient

(2008) Kathleen W. Beekman et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS